IBI308 in Subjects With Advanced/Metastatic Solid Malignancies

NCT03568539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Solid Malignancies

Interventions

DRUG: IBI308

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.